StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker Adjusted SG&A Expense (% of Net Sales) by Quarter

Adjusted SG&A Expense (% of Net Sales) (%)

QuarterlyAnnual

Stryker Adjusted SG&A Expense (% of Net Sales): 32.8% in Q3 2026, unchanged from a year earlier.

Latest, Q3 2026
32.8%
Period ended Sep 30, 2026
Change on a year earlier
0.0 pts
32.8% in Q3 2025
History
27 quarters
Since Q1 2020
Sources
27
Documents cited below

Where the Q3 2026 figure comes from

Reported in Stryker Form 8-K Non-GAAP Reconciliations.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAdjusted SG&A Expense (% of Net Sales) (%)Year on yearSource
Q3 2026Sep 30, 202632.8%0.0 pts0000310764-26-000059|sykex991earningsq32026.htm ↗
Q2 2026Jun 30, 202632.2%-0.9 pts0000310764-26-000048|sykex991earningsq22026.htm ↗
Q1 2026Mar 31, 202635.8%-0.1 pts0000310764-26-000025|sykex991earningsq12026.htm ↗
Q4 2025Dec 31, 202529.7%-1.1 pts0000310764-26-000006|sykex991earningsq42025.htm ↗
Q3 2025Sep 30, 202532.8%-0.4 pts0000310764-25-000126|sykex991earningsq32025.htm ↗
Q2 2025Jun 30, 202533.1%0.0 pts0000310764-25-000103|sykex991earningsq22025.htm ↗
Q1 2025Mar 31, 202535.9%+0.9 pts0000310764-25-000072|sykex991earningsq12025.htm ↗
Q4 2024Dec 31, 202430.8%-0.2 pts0000310764-25-000005|sykex991earningsq42024.htm ↗
Q3 2024Sep 30, 202433.2%-1.3 pts0000310764-24-000113|sykex991earningsq32024.htm ↗
Q2 2024Jun 30, 202433.1%0.0 pts0000310764-24-000095|sykex991earningsq22024.htm ↗
Q1 2024Mar 31, 202435.0%-0.6 pts0000310764-24-000062|sykex991earningsq12024.htm ↗
Q4 2023Dec 31, 202331.0%+0.4 pts0000310764-24-000005|sykex991earningsq42023.htm ↗
Q3 2023Sep 30, 202334.5%+1.4 pts0000310764-23-000114|sykex991earningsq32023.htm ↗
Q2 2023Jun 30, 202333.1%+0.7 pts0000310764-23-000104|sykex991earningsq22023.htm ↗
Q1 2023Mar 31, 202335.6%+0.5 pts0000310764-23-000065|sykex991earningsq12023.htm ↗
Q4 2022Dec 31, 202230.6%-1.5 pts0000310764-23-000005|sykex991earningsq42022.htm ↗

Cite this data

StockData. (2026). Stryker Adjusted SG&A Expense (% of Net Sales) (%), quarterly Q1 2020–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/core-ng-sga-pct

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.